Long-term studies have shown that semaglutide GLP-1 remains effective and safe for weight loss over one to two years
doi: 10.1007/s13300-018-0517-y 93 BollagWB
GLP-1 receptor agonists like semaglutide take the spotlight, enhancing insulin secretion in response to elevated blood sugar levels
However, this decision requires discussion with your doctor about your specific situation, symptoms, and risk factors
Jayne Hornung, chief clinical officer at Managed Markets Insight and Technology, suggests initial pricing of oral GLP-1s for weight loss could be reminiscent of the early days of anti-CGRP medications for migraines when the first oral CGRP came to market in 2019, the pricing still remained high
The durability of results confirms that semaglutide appetite suppression is sustained over extended treatment periods, which matters for people evaluating how long to stay on semaglutide